DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,008 filers reported holding DANAHER CORPORATION in Q1 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,088,060 | -31.4% | 32,600 | -33.6% | 0.03% | -41.7% |
| Q2 2023 | $11,784,000 | -45.2% | 49,100 | -42.4% | 0.05% | -53.4% |
| Q1 2023 | $21,499,012 | -99.3% | 85,300 | +648.2% | 0.10% | +296.2% |
| Q2 2022 | $2,890,128,000 | -79.2% | 11,400 | -75.9% | 0.03% | -77.0% |
| Q1 2022 | $13,874,509,000 | -81.5% | 47,300 | -79.2% | 0.11% | -79.0% |
| Q4 2021 | $74,884,321,000 | +25.4% | 227,605 | +16.0% | 0.54% | +21.9% |
| Q3 2021 | $59,712,252,000 | +1001.0% | 196,138 | +870.5% | 0.44% | +927.9% |
| Q2 2021 | $5,423,555,000 | -47.5% | 20,210 | -56.5% | 0.04% | -56.1% |
| Q4 2020 | $10,321,957,000 | +105.7% | 46,466 | +99.4% | 0.10% | +58.1% |
| Q3 2020 | $5,017,189,000 | +98411.5% | 23,300 | -36.7% | 0.06% | -21.5% |
| Q1 2020 | $5,093,000 | +1406.8% | 36,800 | +1572.7% | 0.08% | +2533.3% |
| Q4 2019 | $338,000 | -93.3% | 2,200 | -93.7% | 0.00% | -93.3% |
| Q3 2019 | $5,027,000 | -77.3% | 34,807 | -77.6% | 0.04% | -77.7% |
| Q2 2019 | $22,181,000 | +2000.5% | 155,200 | +1840.0% | 0.20% | +2144.4% |
| Q1 2019 | $1,056,000 | -51.5% | 8,000 | -62.1% | 0.01% | -52.6% |
| Q4 2018 | $2,179,000 | -76.9% | 21,132 | -75.6% | 0.02% | -62.7% |
| Q3 2018 | $9,421,000 | -1.5% | 86,700 | -10.5% | 0.05% | +2.0% |
| Q2 2018 | $9,563,000 | -17.4% | 96,912 | -22.3% | 0.05% | -21.9% |
| Q4 2017 | $11,584,000 | +44.6% | 124,800 | +31.5% | 0.06% | -1.5% |
| Q2 2017 | $8,010,000 | +1093.7% | 94,913 | +1110.6% | 0.06% | +983.3% |
| Q1 2017 | $671,000 | -93.1% | 7,840 | -93.7% | 0.01% | -92.8% |
| Q4 2016 | $9,731,000 | +88.4% | 125,002 | +89.7% | 0.08% | +76.6% |
| Q3 2016 | $5,166,000 | -41.5% | 65,900 | -36.2% | 0.05% | -58.0% |
| Q2 2015 | $8,838,000 | +98.9% | 103,261 | +99.1% | 0.11% | +111.3% |
| Q4 2014 | $4,444,000 | +20.2% | 51,855 | +6.6% | 0.05% | +29.3% |
| Q3 2014 | $3,696,000 | +1239.1% | 48,644 | +1289.8% | 0.04% | +1266.7% |
| Q2 2014 | $276,000 | -97.7% | 3,500 | -97.8% | 0.00% | -98.0% |
| Q1 2014 | $12,054,000 | +1804.3% | 160,716 | +1860.0% | 0.15% | +2000.0% |
| Q4 2013 | $633,000 | -75.0% | 8,200 | -77.5% | 0.01% | -80.0% |
| Q3 2013 | $2,531,000 | +151.1% | 36,505 | +129.2% | 0.04% | +133.3% |
| Q2 2013 | $1,008,000 | – | 15,929 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |